Teva announces launch of its generic erythromycin tablets usp, used to treat or prevent a variety of bacterial infections, in the united states

Tel aviv, israel & parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), today announced the launch of its 250 mg and 500 mg strength generic erythromycin tablets—a therapeutic equivalent for the reference listed drug (rld) erythromycin tablets from arbor pharmaceuticals. teva generic erythromycin tablets are indicated to treat a variety of bacterial infections, and to prevent initial or recurrent attacks of rheum
TEVA Ratings Summary
TEVA Quant Ranking